Deka Biosciences
Latest round
- Series B
Last raised
- Feb 2023
Total raised
- $46M
Investors
- 8
About Deka Biosciences
Deka Biosciences, Inc. specializes in immunotherapy solutions, leveraging its Diakine™ platform.Deka Biosciences specializes in innovative immunotherapy solutions through its core product offering, the Diakine™ platform. This next-generation cytokine therapy aims to provide personalized treatments for patients suffering from inflammatory diseases and cancer by leveraging unique immune responses. Diakine™ therapies integrate multiple cytokines, such as interleukin-4 and interleukin-10, in a single treatment to enhance therapeutic efficacy while targeting specific inflamed tissues and tumor antigens.Deka Biosciences generates revenue through collaborations with other firms in the biopharmaceutical sector, focusing on B2B transactions with healthcare providers and research institutions. It engages in strategic partnerships to facilitate the development and commercialization of its Diakine™ therapies, which may include licensing agreements or co-development partnerships for clinical trials and product launches. The company aims to enhance its Diakine™ platform and looks to expand its presence in specific markets, particularly in North America and Europe, by developing new immunotherapy solutions that address various inflammatory diseases and cancers. Continued investment in product development is expected, facilitating a strategic pathway for future growth.
Who invested in Deka Biosciences
8 investors across 2 rounds
See all investors in Deka Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Deka Biosciences
Who invested in Deka Biosciences?
Deka Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Deka Biosciences raised?
Deka Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Deka Biosciences last raise money?
Deka Biosciences's most recent round on record is a Series B, in Feb 2023.
What does Deka Biosciences do?
Deka Biosciences is a biotechnology company.
Where is Deka Biosciences headquartered?
Deka Biosciences is headquartered in Germantown, US.
Which VCs invest in companies like Deka Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Deka Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Deka Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.